Identification <i>in Silico</i> and Experimental Validation of Novel Phosphodiesterase 7 Inhibitors with Efficacy in Experimental Autoimmune Encephalomyelitis Mice
Miriam Redondo(Instituto de Química Médica), Nuria E. Campillo(Centro de Investigaciones Biológicas Margarita Salas), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), José Brea(Universidade de Santiago de Compostela), Carmen Gil(Instituto de Salud Carlos III), Daniel I. Pérez(Cedars-Sinai Medical Center), Guadalupe Mengod(Consejo Superior de Investigaciones Científicas), Nuria Paúl-Fernández(Biomedical Research Networking Center on Neurodegenerative Diseases), Santiago Conde(Consejo Superior de Investigaciones Científicas), Concepción Pérez(Instituto de Química Médica), Marı́a Isabel Martı́n(Biomedical Research Networking Center on Neurodegenerative Diseases), Marı́a Isabel Loza(Universidade de Santiago de Compostela), Marı́a Isabel Cadavid(Universidade de Santiago de Compostela)
Cited by 29
Related Papers
Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding
|Journal of Neuroscience|1992|689
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond
|PLoS Pathogens|2016|451
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
|Journal of Medicinal Chemistry|2002|448
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
|Frontiers in Molecular Neuroscience|2011|348